Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (See row 11) Based on 65,293,530 shares of Class A Ordinary Shares, outstanding as of November 4, 2024 reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, filed with the U.S. Securities and Exchange Commission on November 7, 2024 (File No. 001-40598).


SCHEDULE 13G



 
Pfizer Inc. 13-5315170
 
Signature:/s/ Madelyn D. Purcell
Name/Title:Madelyn D. Purcell/Assistant Secretary
Date:02/12/2025